Deadline for HEAP fuel assistance applications is April 30
Eligible Massachusetts residents still have time to apply for the Home Energy Assistance Program (HEAP). Households do not need to be on public assistance or have unpaid bills to qualify. It is open to both renters and homeowners.
LIST: April snow showers bring totals to western Massachusetts
The program sends a one-time payment directly to the heating provider. The funding is made available through a grant and does not have to be repaid.
Residents can find out if they are eligible and apply online, or contact their local administering agency. The application deadline is Wednesday, April 30, 2025, for the 2024-2025 winter heating season.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
41 minutes ago
- Business Wire
Rhythm Express Named by Inc. Magazine as One of the Fastest Growing Private Firms in America
MINNEAPOLIS--(BUSINESS WIRE)-- VivaQuant, Inc. d.b.a. Rhythm Express, a leader in remote cardiac monitoring and digital health solutions, has been recognized as one of the fastest-growing private companies in the United States by Inc. Magazine for the third consecutive year, ranking #331. VivaQuant's continued recognition reflects the company's momentum in reshaping the future of cardiac care through intelligent remote monitoring technologies. 'We are proud of the accomplishments of our team. This is a tremendous honor to make this prestigious list for the third consecutive year. It's a powerful validation of the work we're doing to make cardiac care more accessible, efficient and effective,' said Brian Brockway, CEO of VivaQuant. 'This milestone belongs to our entire team and the providers and patients who trust our solutions every day. We're proud to be driving meaningful change in patient outcomes through our Rhythm Express business and cutting-edge monitoring technologies.' 'This milestone belongs to our entire team and the providers and patients who trust our solutions every day.' — Brian Brockway, CEO Share Innovating the Future of Remote Cardiac Monitoring VivaQuant's flagship offering, Rhythm Express, delivers advanced, near-real time cardiac diagnostics via the small, one-piece, cellular enabled RX-1 mini ™ wearable device and Rhythm Access Portal™. The platform is designed to meet the growing demand for accurate, scalable and user-friendly remote cardiac monitoring services. With a continued focus on innovation and clinical excellence, VivaQuant is well-positioned to lead the next generation of digital cardiovascular care. About VivaQuant, Inc. VivaQuant, Inc. is a digital health company specializing in remote cardiac monitoring and diagnostic services. Through its Rhythm Express platform, VivaQuant combines cutting-edge wearable technology, enhanced proprietary noise removal & analytics, and clinical insight to support better outcomes for patients and providers nationwide.
Business Wire
41 minutes ago
- Business Wire
flyExclusive to Report Second Quarter 2025 Results After Market Today
KINSTON, N.C.--(BUSINESS WIRE)--flyExclusive, Inc. (NYSEAMERICAN: FLYX) announced it will release second quarter 2025 financial results after market close today, August 13, 2025. Management will discuss the financial results during a conference call today at 5:00 pm ET. Interested parties can access the conference call by dialing 877-404-1250 or +1 215-268-9892 and referencing event code 13755397. To access a live webcast of the conference call, please use this link or visit the flyExclusive investor relations website at A replay of the event webcast will be available on said website for twelve months following the conclusion of the call. About flyExclusive flyExclusive is a vertically integrated, FAA-certificated air carrier providing private jet experiences by offering customers a choice of on-demand charter, Jet Club, and fractional ownership services to destinations across the globe. flyExclusive has one of the world's largest fleets of Cessna Citation aircraft, and it operates a combined total of approximately 100 jets, ranging from light to large cabin sizes. The company manages all aspects of the customer experience, ensuring that every flight is on a modern, comfortable, and safe aircraft. flyExclusive's in-house repair station, aircraft paint, cabin interior renovation, and avionics installation capabilities, are all provided from its campus headquarters in Kinston, North Carolina. To learn more, visit
Business Wire
41 minutes ago
- Business Wire
Wenzel Spine Announces Limited U.S. Commercial Launch and First Cases of its Expandable panaSIa™ SI Fusion System
AUSTIN, Texas--(BUSINESS WIRE)--Wenzel Spine, Inc., a medical device company pioneering minimally invasive surgical and analytic solutions for spinal disorders, today announced completion of first cases and the U.S. limited commercial launch of its novel panaSIa™ Expandable SI Fusion System. panaSIa is the first expandable sacroiliac (SI) fusion implant cleared by the FDA and represents a major breakthrough in addressing sacroiliac joint dysfunction with enhanced biomechanical stability and procedural efficiency. Designed to be implanted using a posterior, minimally invasive technique, panaSIa provides joint fixation through controlled expansion across the ilium and sacrum, offering immediate mechanical stability while preserving surrounding tissue. The implant's integrated graft chamber allows for post-expansion bone grafting without disengaging instrumentation, facilitating optimal fusion conditions and minimizing procedural complexity. The first U.S. procedures are part of a limited commercial release taking place at select surgical centers ahead of full launch in Q4 2025. 'panaSIa is unlike any SI fusion device currently available,' said Aaron Calodney, MD, a nationally recognized leader in interventional pain medicine. 'The implant expands to eliminate micro-motion, providing immediate stabilization. By slightly distracting the joint space, it may reduce pain by removing contact between the arthritic surfaces. It's simple, elegant, and biomechanically sound—a truly next-generation solution for SI joint fusion.' The panaSIa system expands Wenzel Spine's portfolio of stand-alone expandable fusion technologies and reflects the company's long-term commitment to minimally invasive innovation and surgeon-driven design. 'This launch is a defining milestone for Wenzel Spine,' said William Wilson, CEO of Wenzel Spine. 'Our team has spent nearly two decades perfecting expandable device design, and panaSIa brings that legacy to a new clinical segment. We are proud to offer providers a differentiated, minimally invasive solution that transforms SI joint fusion with precision, control, and speed.' About panaSIa™ SI Fusion System The panaSIa SI Fusion System is a posteriorly placed, expandable implant that transfixes the ilium and sacrum to immobilize the SI joint and promote fusion. It is offered in two sizes allowing for anatomical customization, while its streamlined instrumentation enables true MIS placement. The integrated expansion mechanism and post-expansion graft delivery system simplify the workflow and reduce operative time. panaSIa is available now in limited release and will be widely available in Q4 2025. About Wenzel Spine, Inc. Headquartered in Austin, Texas, Wenzel Spine, Inc. is a privately held medical technology company committed to advancing the standard of care for spinal disorders through minimally invasive surgical innovation and data-driven solutions. Wenzel Spine's technologies are used by leading spine and pain physicians across the country to streamline surgical procedures and improve patient outcomes. To learn more, visit:
